Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.16B |
| 2 |
Eli Lilly
LLY
|
+$1.9B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.09B |
| 4 |
Cigna
CI
|
+$883M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.49B |
| 2 |
Comcast
CMCSA
|
+$1.34B |
| 3 |
Stryker
SYK
|
+$1.31B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 5 |
Walt Disney
DIS
|
+$1.2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 16.48% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Communication Services | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Chemours
CC
$2.37B
| $218M | 0.03% |
24,612,160
+840,401
| +4% | +$12.1M |
|
477
PTC
PTC
$16B
| $218M | 0.03% |
3,565,274
+619,282
| +21% | +$45.9M |
|
478
Virtu Financial
VIRT
$4.93B
| $218M | 0.03% |
10,472,988
+2,190,794
| +26% | +$40.5M |
|
|
COR
479
DELISTED
Coresite Realty Corporation
COR
| $218M | 0.03% |
1,878,876
+187,979
| +11% | +$20.9M |
|
480
PTC Therapeutics
PTCT
$6.12B
| $218M | 0.03% |
4,878,225
+2,455,383
| +101% | +$124M |
|
481
Pfizer
PFE
$153B
| $217M | 0.03% |
7,017,090
-1,178,891
| -14% | -$40.2M |
|
482
Bilibili
BILI
$7.84B
| $217M | 0.03% |
9,262,141
+3,434,824
| +59% | +$82.9M |
|
483
Theravance Biopharma
TBPH
$877M
| $216M | 0.03% |
9,365,444
+906,787
| +11% | +$22.7M |
|
484
IDEX
IEX
$17.3B
| $216M | 0.03% |
1,563,511
-944,161
| -38% | -$148M |
|
485
Insmed
INSM
$28.6B
| $216M | 0.03% |
13,466,134
+64,606
| +0.5% | +$1.53M |
|
486
LXP Industrial Trust
LXP
$3.57B
| $216M | 0.03% |
4,340,981
+740,498
| +21% | +$39.2M |
|
487
KeyCorp
KEY
$24.4B
| $215M | 0.03% |
20,767,383
+1,040,629
| +5% | +$17.3M |
|
488
Ryanair
RYAAY
$31.3B
| $214M | 0.03% |
10,075,183
+1,245,125
| +14% | +$39.2M |
|
489
Acuity Brands
AYI
$10.8B
| $214M | 0.03% |
2,495,560
+1,043,758
| +72% | +$114M |
|
|
MRTX
490
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $213M | 0.03% |
2,772,713
+756,892
| +38% | +$67.9M |
|
491
Synopsys
SNPS
$79.7B
| $211M | 0.03% |
1,635,998
-220,901
| -12% | -$31.4M |
|
492
Nice
NICE
$5.97B
| $209M | 0.03% |
1,458,287
+140,716
| +11% | +$22.7M |
|
493
eHealth
EHTH
$43.9M
| $209M | 0.03% |
1,482,822
-203,645
| -12% | -$23.3M |
|
494
Omnicom Group
OMC
$23.4B
| $209M | 0.03% |
3,802,944
+1,162,283
| +44% | +$82.5M |
|
495
Sun Communities
SUI
$14.7B
| $208M | 0.03% |
1,663,994
-42,556
| -2% | -$6.43M |
|
496
Charles River Laboratories
CRL
$12.8B
| $208M | 0.03% |
1,646,035
-264,779
| -14% | -$39.7M |
|
497
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $207M | 0.03% |
3,948,693
-117,744
| -3% | -$6.27M |
|
498
LivePerson
LPSN
$32.3M
| $206M | 0.03% |
604,162
-8,179
| -1% | -$3.97M |
|
499
uniQure
QURE
$3.22B
| $206M | 0.03% |
4,336,587
-25,405
| -0.6% | -$1.46M |
|
500
FirstCash
FCFS
$8.78B
| $204M | 0.03% |
2,845,352
-336,606
| -11% | -$27.2M |
|
Similar funds
Fidelity Investments's Q1 2020 Portfolio in Review
As of Q1 2020, Fidelity Investments held 4,600 positions worth $722B, down 20% from $906B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Fidelity Investments's Q1 2020 filing shows 372 new, 1,381 increased, 1,824 reduced and 431 closed positions. Its largest new stake was 1Life Healthcare: 9,509,562 shares worth $164M. The largest sale was Amgen, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Fidelity Investments's largest Q1 2020 buy was 1Life Healthcare: 9,509,562 shares worth $164M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q1 2020, an estimated $2.16B increase.
- Fidelity Investments's biggest Q1 2020 reduction was Amgen, cutting an estimated $1.49B.
- Fidelity Investments fully exited Taubman Centers Inc. in Q1 2020, selling an estimated $106M.
- Fidelity Investments's ten largest holdings make up 27% of its $722B portfolio in Q1 2020.
- Fidelity Investments opened 372 new positions and closed 431 in Q1 2020.
- Fidelity Investments's portfolio value fell 20% quarter-over-quarter to $722B.
Based on Fidelity Investments's 13F filing for Q1 2020, filed 14 May 2020.